Standardsinsybio

SynBio initiatives in industry

Discussion Forum

Check out our Forum and participate in the discussion on standards in the BioTech Industry!

BioTech and SynBio Industry Directory

Biofaction is a research and science communication company with expertise in science communication, film production, technology assessment and the study of ethical, legal and social issues.

Explora Biotech is a Synthetic Biology company that offers a broad range of services for the engineering of biological systems.

DARWIN focuses on the bioprospecting of microorganisms with applications in diverse industries, including agrifood, cosmetics, biorremediation and human probiotics.

Synthetic Biology from Design to Synthesis. Doulix is the only DNA design software that integrates DNA synthesis out of the box.

SynbiCITE has brought people together from different backgrounds, skills, experience, sectors and organisations into a creative environment to drive the adoption of new technology and business models and to accelerate the translation of synthetic biology research into the market place.

Ginkgo Bioworks, founded in 2009, is an American biotech company where organism engineers learn from nature to develop new organisms that replace technology with biology.

SynBioBeta is the premier innovation network for biological engineers, investors, innovators and entrepreneurs who share a passion for using biology to build a better, more sustainable universe.

Leveraging gene engineering technologies to initiate the next wave of innovation in pursuit of cures for cancer and other diseases.

Focused on the development of precisely targeted, controlled and highly active T cell therapies that are designed to offer cancer patients substantial benefits over existing standard of care.

Twist Bioscience develops innovative silicon-based DNA synthesis
platform enables the production of
high-quality synthetic DNA.

Synlogic is working at the intersection of biology and engineering, pioneering the application of synthetic biology to design living therapeutics programmed to treat disease in new ways.

VERVE Therapeutics develops therapies to safely edit the adult genome and confer lifelong protection from cardiovascular disease

Codexis applies their revolutionary CodeEvolver® platform technology to deliver high-performing enzymes and customized solutions in a wide array of applications.

Sherlock Biosciences aims to disrupt diagnostics with better, faster, affordable tests using their unique Engineering Biology platforms.

DNA Script is a team of scientists disrupting how and where DNA synthesis happens by bringing oligo production back to the lab with the world’s first enzymatic DNA printer.

Amyris’ proprietary process of engineering yeasts uses renewably-sourced carbon from plants to make sustainable, custom molecules that allow customers to make better, more effective products that are better for people and for the planet.

Solugen focuses on developing cutting-edge chemical solutions that are safer to
use, more cost-effective, and have a lower environmental impact compared to traditional industrial chemicals.

Calysta is a biotechnology company that focuses on the development and manufacture of protein ingredients from new sources, which will feed the growing population without causing further damage to our planet.

Inscripta’s revolutionary digital genome engineering tools transform how we face complex global challenges and yield solutions that benefit all.

Scout Bio’s mission: to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine.

Global Bioenergies was founded in 2008 to develop a process converting renewable resources (sugar, crops, agricultural and forestry waste) into isobutene, one of the main petroleum derivatives.

Vedanta Biosciences focus on rational design of drugs made of defined consortia of bacteria that are essential dwellers of the gut ecosystem.

Strateos’ mission is to turn biology into an information technology, driven by data, computation, and high-throughput robotics with the goal of substantially advancing drug discovery.

EdiGene is a biotechnology company with a mission to translate the cutting-edge genome editing technologies into novel therapeutics for genetic diseases and cancer, and into creative solutions to advance drug discovery.

Checkerspot’s technology unlocks and expands nature’s palette of materials, and produces building blocks for new materials that can be scaled through commercial fermentation.

CB Therapeutics is an innovative producer of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems.

Vigene Biosciences offers research-grade and cGMP production of AAV, lentivirus, retrovirus, adenovirus, and plasmid that complies with FDA and EMA guidelines.

Arcardia Bioscience focuses on innovating crops to provide high-value, healthy food ingredients to help meet consumer demand for a healthier diet.

Strand was co-founded by MIT biological engineers, building on the idea of creating smart therapies capable of making autonomous decisions through building the world’s first mRNA “programming language,” the only platform of its kind for advanced mRNA smart therapeutics.